✨ Exciting news out of RetiSpec today! ✨ We are thrilled to announce that we have secured $10M USD in our latest funding round led by iGan Partners, which included new strategic investors, Eli Lilly and Company and Topcon Healthcare, Inc., along with existing investors, Gentex Corporation, the Alzheimer's Drug Discovery Foundation’s Diagnostics Accelerator, Verge HealthTech Fund, University of Minnesota’s Discovery Capital, Ontario Brain Institute, Centre for Aging Brain Health Innovation, and private investors. For the full details, check out this link: https://lnkd.in/gPhtShzh The RetiSpec team will be in full force at the #AAIC2024 conference! Please be in touch if you’d like to connect: [email protected]
RetiSpec
Software Development
Toronto, ON 3,727 followers
RetiSpec is developing medical AI for the early detection of Alzheimer’s disease through a simple eye test.
About us
RetiSpec is an AI-based company focused on early detection of neurodegenerative diseases through a simple eye exam. RetiSpec's proprietary AI solution leverages existing retinal imaging cameras to provide a non-invasive, accurate and scalable solution for the early detection of Alzheimer's disease. RetiSpec is involved in multiple Alzheimer's and brain health studies in leading hospitals and research networks throughout North America. RetiSpec is currently advancing its regulatory and market entry plans for its first clinically-validated test to predict amyloid burden at the point of care, to aid in the evaluation of individuals for Alzheimer's disease and other causes of cognitive decline. RetiSpec was recently selected from more than 75 global applicants to receive the Davos Alzheimer's Collaborative inaugural grant for Health System Preparedness to test its technology in optometry settings.
- Website
-
http://retispec.ai
External link for RetiSpec
- Industry
- Software Development
- Company size
- 11-50 employees
- Headquarters
- Toronto, ON
- Type
- Privately Held
- Founded
- 2016
- Specialties
- Artificial Intelligence and Medical Software
Locations
-
Primary
Toronto, ON, CA
Employees at RetiSpec
Updates
-
What a fun surprise to see that RetiSpec has been featured in Forbes! 🎉 This recognition highlights our innovative work in AI-based detection of amyloid using widely available fundus cameras, pushing the boundaries of what’s possible in #vision technology. A huge shoutout to Toku Eyes, a fellow Topcon Healthcare portfolio company, for also being featured—together, we’re making strides in the industry! Special thanks to VSP Global Innovation Center (especially Ruth Yomtoubian and Will Flanagan) for being a trailblazer in identifying new trends in vision technology and fostering an environment of innovation. Your support and leadership are invaluable as we work to transform the landscape. Check out the full article to learn more about the exciting developments in our field! 👇 https://lnkd.in/gf3Qs2dB #VisionTech #Innovation #EyeCare #AI #HealthTech #RetiSpec #ENDALZ #Alzheimersdisease #AAIC2024
-
Check out this amazing feature of our #optometry-based screening program for #Alzheimer's disease in Zoomer Magazine! 🤩 Thank you to our incredible partners at the Ontario Brain Institute for highlighting this impactful work. We couldn't have done it without our wonderful partners at Toronto Memory Program and Alzheimer Society of Toronto 🙏 To learn more about the impact of our #community-based screening program for early detection of #alzheimersdisease, check out the latest issue 👇 https://lnkd.in/gPK_KjwQ
The Ontario Brain Institute is Bringing Brain Health to a Community Near You
everythingzoomer.com
-
Thanks for the shoutout, MaRS Discovery District! 🤩 To learn more about our recent partnership with Topcon Healthcare: https://lnkd.in/e4xP7c-W
Check out our latest monthly roundup, highlighting the biggest MaRS success stories of the past month! CIBC, TerraFixing, Planetary, Arca, Topcon Healthcare, RetiSpec, Forcen Inc., Nfinite Nanotech.
-
We are honored to stand alongside an inspiring cohort of incredible innovators and thrilled to join StartUp Health's Alzheimer's Moonshot Community! 🧠 💪 This initiative is a groundbreaking step towards accelerating research and innovation in the fight against Alzheimer's disease. Thank you Phyllis Ferrell, Alzheimer's Drug Discovery Foundation, Gates Ventures, Steven Krein and his incredible team StartUp Health! #AlzMoonshot #Alzheimers
Excited to announce the first 14 companies to join StartUp Health's Alzheimer's Moonshot Community, launched earlier this year with support from Gates Ventures & Alzheimer's Drug Discovery Foundation. I just got off a virtual community kickoff session with our team and founders from all 14 companies (across 6 countries) and am feeling inspired, optimistic, and encouraged about how this group can make orogres, together, in the AD/ADRD space. 💜 A warm welcome 👋 to Marta Barrachina of ADmit Therapeutics, Venkat Shastri of ALZpath Inc., Christy K. Sheehy-Bensinger, PhD of C. Light Technologies, Inc., Luca Giani of Ilios Therapeutics, Ryan Field of Kernel, Nina Kiwit & Manuel Kraus of MindAhead, Paul Campbell & Jen Flexman, PhD, of Moneta Health, Nathan Intrator of Neurosteer, Eliav Shaked & Catherine Bornbaum, PhD, of RetiSpec, Ken Mariash of Sinaptica Therapeutics, Steven Visuri & Ryan Gordon of Stem Pharm, Fernando Johann of TELL Toolkit, Erwin L Roggen of ToxGenSolutions BV (TGS), and Allyson Schrier & William A. Uniowski of Zinnia. Phyllis Ferrell #AlzMoonshot #Alzheimers
StartUp Health Announces First Companies to Join Alzheimer's Moonshot Community — StartUp Health
startuphealth.com
-
RetiSpec reposted this
As an exciting follow up to RetiSpec's partnership with Topcon Healthcare, Inc., I am thrilled to share that this collaboration is being elevated by Topcon Healthcare's new partnership with Microsoft to deliver AI-powered 'Healthcare from the Eye' solutions at scale. ✨ This partnership marks a significant step forward in our collective mission to revolutionize 'Healthcare from the Eye' through early detection of neurodegenerative diseases, starting with #Alzheimer's disease. Together, we are committed to bringing neurology and eye care closer together, driving towards earlier detection and improved outcomes for patients. To learn more about the Topcon Healthcare collaboration with Microsoft, see here: https://lnkd.in/gA-4238G To learn more about the partnership between RetiSpec and Topcon Healthcare Inc., see here: https://lnkd.in/g6eRUsCY
-
RetiSpec reposted this
Awesome News! Topcon Healthcare announced their partnership with Microsoft!! Last week, we had the wonderful opportunity to join Ali Tafreshi, Robert N. Weinreb, MD, and David Rhew, M.D. at Seattle’s iconic Chihuly Garden and Glass Museum as they introduce their vision to the #ARVO2024 community. To learn more, watch this 🎬: https://lnkd.in/gk2ne9qu At RetiSpec, we are proud to join these unstoppable forces as they deliver AI-powered 'Healthcare from the Eye' solutions, and bring #neurology and #eyecare closer together.
-
Congratulations to our partners at Topcon Healthcare Inc. on their visionary partnership with Microsoft to deliver AI-powered 'Healthcare from the Eye' solutions. This collaboration aims to empower patients and providers with innovative solutions for early detection of neurological and systemic diseases through the eye. At RetiSpec, we are delighted by this transformative collaboration with Microsoft as it builds on our shared commitment to accelerate the commercialization and scale of RetiSpec's first brain health indication in #Alzheimer's disease. As noted by esteemed ophthalmologist, Dr. Robert Weinreb, MD, “‘Healthcare from the Eye’ is no longer just a concept; it is the future of healthcare.” At RetiSpec, we’re honored to be a part of this exciting and impactful future. 🚀 Learn more about RetiSpec's innovative AI solutions at retispec.ai #AIHealthcare #HealthcareInnovation #TopconHealthcare #MicrosoftHealthcare #Microsoft #RetiSpec #HealthcareFromTheEye #Alzheimers #ENDALZ #HealthTech #BrainHealth #AlzheimersDisease #EarlyDetection #Neurology #Ophthalmology #Optometry #EyeCare #AAIC2024 #CTAD2024 #MedTech #AI #HealthcareTransformation #AlzheimersResearch https://lnkd.in/gEX_jxT7
Topcon Healthcare Inc. (THI) Partners with Microsoft to Deliver AI-Powered ‘Healthcare from the Eye’ Through a Connected Healthcare Platform
businesswire.com
-
🌟 Exciting News from RetiSpec and Topcon Healthcare, Inc.! 🌟 We are thrilled to announce a groundbreaking collaboration between RetiSpec, Inc. and Topcon Healthcare, Inc. aimed at advancing the development and commercialization of RetiSpec’s AI-powered eye diagnostics for brain health. This partnership includes an investment in RetiSpec and marks a significant step forward in our shared mission to revolutionize 'Healthcare from the Eye' through early detection of neurodegenerative diseases, starting with #Alzheimer's disease. RetiSpec’s technology aims to help healthcare providers predict amyloid burden, a core biomarker of Alzheimer’s disease. Currently, the test is available for Research Use Only; once commercialized and integrated with Topcon Harmony, a device-inclusive and cloud-based clinical data management platform, it will enable early detection of Alzheimer’s disease and facilitate timely access to care. This collaboration marks a significant milestone in our mission to bring cutting-edge AI diagnostics from the eye to the forefront of healthcare. Together, we are committed to bringing neurology and eye care closer together, driving towards earlier detection and improved outcomes for patients. For more information on RetiSpec and our mission, visit our website: retispec.ai #RetiSpec #TopconHealthcareInc #BrainHealth #AlzheimersDisease #Alzheimers #AIInnovation #HealthTech #AlzheimersDetection #Neurology #Ophthalmology #HealthcareTransformation #ENDALZ #AAIC2024 #CTAD2024 #MedTech #Neurology #AI #Optometry #Ophthalmology #AlzheimersResearch https://lnkd.in/gnDxzd7i
RetiSpec,Topcon Healthcare, Inc. Announce Collaboration, Investment to Help Bring Eye-Based AI Diagnostic Tool to Market
prnewswire.com
-
“In recent years, scientists have made startling advances in their ability to detect #Alzheimer’s disease in the early stages, when treatments are most effective… This good news brings a new challenge: getting these tests and treatments to the millions of people in all corners of the world who need them,” says George Vradenburg, founding chairman of the Davos Alzheimer's Collaborative and Olivier Schwab, managing director of the World Economic Forum. At RetiSpec, we share this optimism and are working to address the challenge of enabling widespread early and accurate detection of #AlzheimersDisease through AI-powered eye scans. Thank you to the incredible teams at Scientific American and the Davos Alzheimer's Collaborative for featuring RetiSpec in your special edition on The New Age of Alzheimers! This special issue features contributions from Bill Gates, former NIH director Elias Zerhouni, and other global leaders in #health and #aging. 👁 Check out the piece on RetiSpec here: https://lnkd.in/ge_RYG-k 🧠 You can view and download a digital copy of the full magazine here: https://lnkd.in/e8Y6rcie Our deepest thanks to Phyllis Ferrell, Drew Holzapfel, George Vradenburg, and Jeremy Abbate for including us in this important conversation 🙏
Scientific American
scientificamerican.com